Neutrogena Invisible Daily Defense Body Spray Sunscreen Recall
Johnson & Johnson Consumer, Inc. is recalling Neutrogena Invisible Daily Defense body spray sunscreen (SPF 60+) due to cGMP deviations. The recall affects approximately 88,380 cans distributed nationwide.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall initiated voluntarily by the firm for cGMP deviations. The source text does not report any illnesses, injuries, or safety incidents—only manufacturing practice violations. Per the rubric, Class II recalls without reported harm and addressing manufacturing issues are typically scored as Moderate (2).
Plain-English summary
Johnson & Johnson Consumer, Inc. is voluntarily recalling Neutrogena Invisible Daily Defense body spray sunscreen (BROAD SPECTRUM SPF 60+) in 5.0 oz. aerosol cans. The product contains Avobenzone (3%), Homosalate (10%), Octisalate (5%), and Octocrylene (10%), with UPC 0 86800 11154 2.
The recall was initiated due to cGMP (Current Good Manufacturing Practice) deviations identified in the manufacturing process. This is a Class II recall.
The affected product was distributed nationwide in the United States. Approximately 88,380 cans are subject to this recall. All lots within expiration date are included.
Consumers who have purchased this product should stop using it. Consumers with questions may contact the recalling firm, Johnson & Johnson Consumer, Inc., located at 199 Grandview Rd, Skillman, NJ 08858-1311.
The recalled product
- Product
- Neutrogena Invisible Daily defense body spray sunscreen BROAD SPECTRUM SPF 60+, Avobenzone (3%), Homosalate (10%), Octisalate (5%), Octocrylene (10%), NET WT. 5.0 OZ. (141 g) aerosol can, Distributed by: JOHNSON & JOHNSON CONSUMER, INC. Skillman, NJ 08858, UPC 0 86800 11154 2
- Manufacturer
- Johnson & Johnson Consumer, Inc.
- Hazard
- cgmp-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots within expiry.
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27